OTX-TKI-2023-AMD-303, NCT06495918: Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Axitinib Implant) in Subjects With Neovascular Age- Related Macular Degeneration |
|
|
| Recruiting | 3 | 825 | US | OTX-TKI, Aflibercept | Ocular Therapeutix, Inc., Fortrea, Duke University | Neovascular Age-related Macular Degeneration | 01/27 | 01/27 | | |